AAAAAA
Results:
1-13
|
Results: 13
Authors:
FRITSCHE M
MUNDT M
MERKLE C
JAHNE R
GRONER B
Citation: M. Fritsche et al., P53 SUPPRESSES CYTOKINE-INDUCED, STAT5 MEDIATED ACTIVATION OF TRANSCRIPTION, Molecular and cellular endocrinology, 143(1-2), 1998, pp. 143-154
Authors:
SELIVANOVA G
IOTSOVA V
OKAN I
FRITSCHE M
STROM M
GRONER B
GRAFSTROM RC
WIMAN KG
Citation: G. Selivanova et al., RESTORATION OF THE GROWTH SUPPRESSION FUNCTION OF MUTANT P53 BY A SYNTHETIC PEPTIDE DERIVED FROM THE P53 C-TERMINAL DOMAIN, Nature medicine, 3(6), 1997, pp. 632-638
Authors:
MUNDT M
HUPP T
FRITSCHE M
MERKLE C
HANSEN S
LANE D
GRONER B
Citation: M. Mundt et al., PROTEIN INTERACTIONS AT THE CARBOXYL-TERMINUS OF P53 RESULT IN THE INDUCTION OF ITS IN-VITRO TRANSACTIVATION POTENTIAL, Oncogene, 15(2), 1997, pp. 237-244
Authors:
PLAUMANN B
FRITSCHE M
RIMPLER H
BRANDNER G
HESS RD
Citation: B. Plaumann et al., FLAVONOIDS ACTIVATE WILD-TYPE P53, Oncogene, 13(8), 1996, pp. 1605-1614
Authors:
SIUCIAK JA
BOYLAN C
FRITSCHE M
ALTAR CA
LINDSAY RM
Citation: Ja. Siuciak et al., BDNF INCREASES MONOAMINERGIC ACTIVITY IN RAT-BRAIN FOLLOWING INTRACEREBROVENTRICULAR OR INTRAPARENCHYMAL ADMINISTRATION, Brain research, 710(1-2), 1996, pp. 11-20
Authors:
JONES BE
BOYLAN CB
FRITSCHE M
JUHASZ M
JACKSON C
WIEGAND SJ
HYMAN C
LINDSAY RM
ALTAR CA
Citation: Be. Jones et al., A CONTINUOUS STRIATAL INFUSION OF 6-HYDROXYDOPAMINE PRODUCES A TERMINAL AXOTOMY AND DELAYED BEHAVIORAL-EFFECTS, Brain research, 709(2), 1996, pp. 275-284
Authors:
RADKA SF
HOLST PA
FRITSCHE M
ALTAR CA
Citation: Sf. Radka et al., PRESENCE OF BRAIN-DERIVED NEUROTROPHIC FACTOR IN BRAIN AND HUMAN AND RAT BUT NOT MOUSE SERUM DETECTED BY A SENSITIVE AND SPECIFIC IMMUNOASSAY, Brain research, 709(1), 1996, pp. 122-130
Authors:
SIEGEL J
FRITSCHE M
MAI S
BRANDNER G
HESS RD
Citation: J. Siegel et al., ENHANCED P53 ACTIVITY AND ACCUMULATION IN RESPONSE TO DNA-DAMAGE UPONDNA TRANSFECTION, Oncogene, 11(7), 1995, pp. 1363-1370
Authors:
HESS R
PLAUMANN B
LUTUM AS
HAESSLER C
HEINZ B
FRITSCHE M
BRANDNER G
Citation: R. Hess et al., NUCLEAR ACCUMULATION OF P53 IN RESPONSE TO TREATMENT WITH DNA-DAMAGING AGENTS, Toxicology letters, 72(1-3), 1994, pp. 43-52
Authors:
ALTAR CA
BOYLAN CB
FRITSCHE M
JONES BE
JACKSON C
WIEGAND SJ
LINDSAY RM
HYMAN C
Citation: Ca. Altar et al., EFFICACY OF BRAIN-DERIVED NEUROTROPHIC FACTOR AND NEUROTROPHIN-3 ON NEUROCHEMICAL AND BEHAVIORAL DEFICITS ASSOCIATED WITH PARTIAL NIGROSTRIATAL DOPAMINE LESIONS, Journal of neurochemistry, 63(3), 1994, pp. 1021-1032
Authors:
ALTAR CA
BOYLAN CB
FRITSCHE M
JACKSON C
HYMAN C
LINDSAY RM
Citation: Ca. Altar et al., THE NEUROTROPHINS NT-4 5 AND BDNF AUGMENT SEROTONIN, DOPAMINE, AND GABAERGIC SYSTEMS DURING BEHAVIORALLY EFFECTIVE INFUSIONS TO THE SUBSTANTIA-NIGRA/, Experimental neurology, 130(1), 1994, pp. 31-40
Authors:
ALTAR CA
SIUCIAK J
BOYLAN C
FRITSCHE M
HYMAN C
WIEGAND SJ
ALDERSON R
LINDSAY RM
Citation: Ca. Altar et al., EFFECTS OF BDNF AND NT-3 ON SEROTONIN DOPAMINE, AND ACETYLCHOLINE NEURONS IN-VIVO, Journal of neurochemistry, 61, 1993, pp. 190000007-190000007
Authors:
ALTAR CA
BOYLAN CB
FRITSCHE M
JACKSON C
JONES BE
WIEGAND SJ
LINDSAY RM
HYMAN C
Citation: Ca. Altar et al., THE NEUROTROPHINS BDNF AND NT-3 PROMOTE NEUROCHEMICAL AND BEHAVIORAL FUNCTION AFTER NIGROSTRIATAL DOPAMINE LESION, Journal of neurochemistry, 61, 1993, pp. 190000117-190000117
Risultati:
1-13
|